MTOR and non-small cell lung carcinoma: Positive crosstalk between the TβR, AXL, Wnt/β-catenin, and EGFR can contribute to the activation of PI3K/Akt/mTOR signaling, blocking apoptotic pathways in NSCLC [3,7,58].